These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8868896)

  • 1. Critical care. Inotrope therapy.
    Place B
    Nurs Times; 1996 Aug 28-Sep 3; 92(35):55-7. PubMed ID: 8868896
    [No Abstract]   [Full Text] [Related]  

  • 2. Intermittent inotrope infusion for end stage heart failure in Duchenne muscular dystrophy.
    van Baalen A; von Spiczak S; Stephani U; Fischer G
    Neuromuscul Disord; 2008 Dec; 18(12):1005-6; author reply 1006. PubMed ID: 18952428
    [No Abstract]   [Full Text] [Related]  

  • 3. The cul-de-sac at the end of the road.
    Stevenson LW
    J Card Fail; 2003 Jun; 9(3):188-91. PubMed ID: 12815568
    [No Abstract]   [Full Text] [Related]  

  • 4. Outpatient continuous inotrope infusion as an adjunct to heart failure therapy in Duchenne muscular dystrophy.
    Cripe LH; Barber BJ; Spicer RL; Wong BL; Weidner N; Benson DW; Markham LW
    Neuromuscul Disord; 2006 Nov; 16(11):745-8. PubMed ID: 17005398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous inotropic agents in the intensive therapy unit: do they really make a difference?
    Opasich C; Russo A; Mingrone R; Zambelli M; Tavazzi L
    Eur J Heart Fail; 2000 Mar; 2(1):7-11. PubMed ID: 10742697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dobutamine rescue for intractable CHF.
    Schactman M; Crawford MV
    Am J Nurs; 1988 Dec; 88(12):1642-3. PubMed ID: 3195632
    [No Abstract]   [Full Text] [Related]  

  • 7. Managing dobutamine infusions.
    Scrima DA
    Medsurg Nurs; 1993 Dec; 2(6):459-65. PubMed ID: 8260998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Infusion of inotropic agents at home in patients with severe heart failure: an important role for the nurse practitioner].
    Ypenburg C; Verwey HF; van der Wall EE
    Ned Tijdschr Geneeskd; 2007 Nov; 151(44):2426-8. PubMed ID: 18064859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dobutamine infusion for the treatment of congestive heart failure in the home care setting.
    Coffin MR
    J Intraven Nurs; 1994; 17(3):145-50. PubMed ID: 8064499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure.
    Drakos SG; Kanakakis JV; Nanas S; Bonios M; Kaldara E; Katsaros F; Pantsios C; Nanas JN
    J Cardiovasc Pharmacol; 2009 Feb; 53(2):157-61. PubMed ID: 19188832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous heart failure medications: an update for home health clinicians.
    Sherrod MM; Graulty R; Crawford M; Cheek DJ
    Home Healthc Nurse; 2009; 27(10):610-9; quiz 620-1. PubMed ID: 19907237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart failure management.
    Blankenship JS
    J Nurs Adm; 1999 Nov; 29(11):6. PubMed ID: 10565311
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure.
    Gorodeski EZ; Chu EC; Reese JR; Shishehbor MH; Hsich E; Starling RC
    Circ Heart Fail; 2009 Jul; 2(4):320-4. PubMed ID: 19808355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure.
    Adamopoulos S; Parissis JT; Iliodromitis EK; Paraskevaidis I; Tsiapras D; Farmakis D; Karatzas D; Gheorghiade M; Filippatos GS; Kremastinos DT
    Am J Cardiol; 2006 Jul; 98(1):102-6. PubMed ID: 16784930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intravenous positive inotropic therapy on myocardial damage in patients with dilated cardiomyopathy.
    Albayrak F; Demircan S; Yazici M; Arslandağ M
    Anadolu Kardiyol Derg; 2008 Feb; 8(1):69. PubMed ID: 18258539
    [No Abstract]   [Full Text] [Related]  

  • 16. Nesiritide: the latest drug for treating heart failure.
    Fontana D
    Crit Care Nurse; 2006 Feb; 26(1):39-44, 46-7. PubMed ID: 16443809
    [No Abstract]   [Full Text] [Related]  

  • 17. [Current views on Milrinon--a PDE-III-inhibitor].
    Anaesthesist; 1994 Mar; 43(3 Suppl):1-16. PubMed ID: 9209531
    [No Abstract]   [Full Text] [Related]  

  • 18. The comparison of the effects of AR-L 115 BS and dobutamine in patients with severe cardiac failure.
    Klein G; Sauer E; Bauer R; Wirtzfeld A; Sebening H
    Arzneimittelforschung; 1981; 31(1a):257-9. PubMed ID: 7195236
    [No Abstract]   [Full Text] [Related]  

  • 19. Intermittent dobutamine treatment in patients with chronic refractory congestive heart failure: a randomized, double-blind, placebo-controlled study.
    Elis A; Bental T; Kimchi O; Ravid M; Lishner M
    Clin Pharmacol Ther; 1998 Jun; 63(6):682-5. PubMed ID: 9663183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A bridge for the 21st century in heart transplantation?
    Felker GM; O'connor CM
    Am Heart J; 2003 Feb; 145(2):198-9. PubMed ID: 12595831
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.